The ASAM Fundamentals of Addiction Medicine - Virtual Live Workshop - October 6, 7, 13 and 14, 2020 - In collaboration with Caron Treatment Centers

Product not yet rated

Includes a Live Event on 10/06/2020 at 1:00 PM (EDT)

  • Register
    • Honorary Member - $129
    • CRT Member - $129
    • Non-Member - $129
    • Regular Member - $129
    • Retired - $129
    • Early Career Physician - $129
    • Resident - $129
    • Student - $129
    • Associate - $129
    • ASAM Staff - Free!
    • International Member - $129
    • Emeritus Member - $129
    • Provisional Member - $129
    • Fellow Member - $129
    • Honorary Member - $129
    • CRT Member - $129
image

in collaboration with

image

Registration Information

This virtual workshop will be held online over the course of four days. Participants should plan to attend all four days at the designated times:

  • Tuesday, October 6 | 1:00 pm - 3:00 pm (ET)
  • Wednesday, October 7 | 1:00 pm - 4:00 pm (ET)
  • Tuesday, October 13 | 1:00 pm - 3:30 pm (ET)
  • Wednesday, October 14 | 1:00 pm - 4:00 pm (ET)

Cost: $129 per attendee.  

Register for the ASAM Fundamentals of Addiction Medicine AND Caron Treatment Center's 5th Annual Addiction Research Symposium together for a $30 discount!  Please add both the Fundamentals AND the Caron Symposium products to your e-Learning Center shopping cart to receive the discount.

Overview

The ASAM Fundamentals of Addiction Medicine is an innovative, case-based workshop designed for providers new to the field of addiction medicine in settings such as primary care, emergency care, and behavioral health, who see patients at risk for or with substance use disorders (SUDs). Participants will learn more about addiction medicine and how to screen, diagnose, treat, and/or refer patients with addiction*. Addiction is a disease that continues to devastate our communities, but there are treatments available to help patients. Participants of this workshop will learn more about addiction medicine and how to screen, diagnose, treat, and/or refer patients with addiction – many of whom are already being seen for commonly occurring medical and psychiatric comorbidities. 

This live virtual workshop is designed to be energetic and interactive. Sessions throughout the series will include lecture, demonstration of skills and skill building. Participants should plan to attend all four days of sessions at the designated dates and times above. Sessions will be recorded for participants to view after the series concludes. 

*Note: This program is the first activity in The ASAM Fundamentals of Addiction Medicine 40-Hour Program, an innovative educational program designed to translate the science of addiction medicine into transformative, positive outcomes for patients by empowering primary care and other providers to diagnose and treat patients at risk for or with addiction. Participants of this live workshop will receive a discount off the registration price for the full 40-Hour Program, featuring over 80 hours of CME content to choose from and a community of mentors and colleagues for additional support with complex patients! To learn more visit: https://www.asam.org/education/live-online-cme/fundamentals-program

Learning Objectives

Upon completion of this educational activity, participants should be able to:
  1. Identify one's own feelings and attitudes that promote or prevent therapeutic responses to patients with substance use disorders.
  2. Demonstrate a knowledge of the diseased brain processes when treating patients with addictive behaviors.
  3. Use validated patient screening tools to detect substance use and interpret a spectrum of results.
  4. Use motivational interviewing to enhance patient's readiness to change risky behaviors.
  5. Offer the interventions that are appropriate to specific substances and severity of usage pattern.
    1. Respond to hazardous drinking with brief counseling strategies, appropriate to the patient's readiness to change.
    2. For patients suspected of having a SUD, conduct a biopsychosocial assessment to provide a diagnosis and match the patient to an appropriate level of care.
  6. Prescribe pharmacotherapy appropriately for alcohol, tobacco, and opioid use disorders.
  7. Offer patients and families information and referral to behavioral interventions including support groups and mutual aid groups that assist in the recovery process.

Registration Cancellation Policy

Please email education@asam.org for all cancellation requests or issues/concerns if a day is no longer feasible with your schedule. We will do our best to work with participants who are unable to attend for urgent responsibilities to ensure all CME hours can be claimed.

Questions?

If you have any questions or comments, please feel free to reach out to Samantha Cribari-Starr, Director of Professional Development at ASAM.  

Key:

Complete
Failed
Available
Locked
Pre-Workshop Assessments
Pre-Workshop Assessment Part 1
25 Questions  |  1 attempt  |  1/25 points to pass
25 Questions  |  1 attempt  |  1/25 points to pass Participants will assess attitude about, knowledge, competence and confidence of substance use disorders pre-workshop.
Pre-Workshop Assessment Part 2
6 Questions
6 Questions Participants will assess attitude towards, knowledge, competence and confidence of substance use disorders pre-workshop.
Virtual Sessions
Day 1 - Virtual Session 1 (October 6, 2020 - 1:00 pm ET)
Day 1 - Virtual Session 1 (October 6, 2020 - 1:00 pm ET)
10/06/2020 at 1:00 PM (EDT)   |  120 minutes
10/06/2020 at 1:00 PM (EDT)   |  120 minutes Session 1: An Introduction to Addictive Disorders and the Clinical Manifestations of the Neurobiology of Addiction
Day 1 Evaluation
3 Questions
3 Questions Please complete the evaluation for each session.
Day 2 - Virtual Session 2 (October 7, 2020 - 1:00 pm ET)
Day 2 - Virtual Session 2 (October 7, 2020 - 1:00 pm ET)
10/07/2020 at 1:00 PM (EDT)   |  180 minutes
10/07/2020 at 1:00 PM (EDT)   |  180 minutes Session 2: Identifying Unhealthy Substance Use: Assessment and For Every ill, There May Be a Pill: Treating Substance Use Disorders with Medication and Counseling
Day 2 Evaluation
3 Questions
Day 3 - Virtual Session 3 (October 13, 2020 - 1:00 pm ET)
Day 3 - Virtual Session 3 (October 13, 2020 - 1:00 pm ET)
10/13/2020 at 4:00 PM (EDT)   |  150 minutes
10/13/2020 at 4:00 PM (EDT)   |  150 minutes Session 3: Should I Open Pandora’s Box? Screening, Brief Intervention, and Referral to Treatment (SBIRT)
Day 3 Evaluation
3 Questions
Day 4 - Virtual Session 4 (October 14, 2020 - 1:00 pm ET)
Day 4 - Virtual Session 4 (October 14, 2020 - 1:00 pm ET)
10/14/2020 at 1:00 PM (EDT)   |  180 minutes
10/14/2020 at 1:00 PM (EDT)   |  180 minutes Session 4: When Your Patient says Yes, But! A “Taste” of Motivational Interviewing
Day 4 Evaluation
3 Questions
Post-Workshop Assessments & Certificate
Post-Workshop Assessment Part 1
25 Questions  |  1 attempt  |  1/25 points to pass
25 Questions  |  1 attempt  |  1/25 points to pass Participants of the ASAM Fundamentals workshop will assess attitude about, knowledge, competence and confidence of substance use disorders post-workshop.
Post-Workshop Assessment Part 2
20 Questions
20 Questions Participants of the ASAM Fundamentals workshop will assess attitude towards, knowledge, competence and confidence of substance use disorders post-workshop.
Credit & Certificate
Up to 8.00 medical credits available  |  Certificate available
Up to 8.00 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.

Session 1: An Introduction to Addictive Disorders and the Clinical Manifestations of the Neurobiology of Addiction

DAY 1 - October 6, 2020; 1:00 pm - 3:00 pm ET

The first part of this session you will (1) be immediately engaged through a powerful, visual medium; (2) identify and reflect upon their individual affective response to the disease of substance use disorder and their patients who show evidence of this disease, and (3) identify and discuss the many factors associated with SUD, e.g., enabling behaviors of others in the life of the person who is using substances, the effect of pejorative language when caring for people who use substances, etc. 

The second part of the session will introduce the neurobiology of SUD, highlighting that this is a chronic illness and noting that the point of first entry into the healthcare system is through the primary care physician.

ActivityTiming
ASAM Welcome and Instructions 20 Min
Session 1: Overview and An Introduction to Addictive Disorders45 Min
Session 2: The Clinical Manifestations of the Neurobiology of Addiction45 Min
Day 1 Wrap-Up and Housekeeping10 Min
Total Time Day 12 Hour

Session 2: Identifying Unhealthy Substance Use: Assessment and For Every ill, There May Be a Pill: Treating Substance Use Disorders with Medication and Counseling

DAY 2 - October 7, 2020; 1:00 pm - 4:00pm ET

The first part of this session will provide an overview of the assessment and treatment plan for patients with severe addictive disorders. Ben’s case will be continued with a biopsychosocial assessment and corresponding recommended treatment plan. The ASAM Patient Placement Criteria will be introduced, and participants will practice using these criteria. The second part of this session will engage participants in dialogue about medications and behavioral treatments including mutual aid groups that may be used to treat three types of SUDs: alcohol, tobacco, opioids.

ActivityTiming
ASAM Welcome and Instructions20 Min
Session 3: Identifying Unhealthy Substance Use: Assessment 1 Hour
Session 4: For Every ill, There May Be a Pill: Treating Substance Use Disorders
With Medication and Counseling
1 Hour, 30 Min
Day 2 Wrap-Up and Housekeeping10 Min
Total Time Day 23 Hour

Session 3: Should I Open Pandora’s Box? Screening, Brief Intervention, and Referral to Treatment (SBIRT)

DAY 3 - October 13, 2020; 1:00 pm - 3:30 pm ET

The purpose of this session is to provide further training and skills practice in screening and brief intervention with consequent indicated referral to treatment for persons with alcohol use or substance use disorder.

ActivityTiming
ASAM Welcome and Instructions20 Min
Session 5: Should I Open Pandora’s Box?: Screening, Brief Intervention,
and Referral to Treatment (SBIRT)
2 Hour
Day 3 Wrap-Up and Housekeeping10 Min
Total Time Day 32 Hour, 30 Min

Session 4: When Your Patient says Yes, But! A “Taste” of Motivational Interviewing

DAY 4 - October 14; 1:00 pm to 4:00 pm ET

The purpose of this session is to introduce the approach to motivational interviewing and provide an opportunity for participants to practice using the MI approach in interacting with patients.

ActivityTiming
ASAM Welcome and Instructions20 Min
Session 6: When Your Patient says Yes, But!: A “Taste” of Motivational
Interviewing
2 Hour, 25 Min
Day 4 Wrap-Up15 Min
Total Time Day 43 Hour

Joseph M. Garbely

DO, DFASAM

As executive vice president of medical services and chief medical officer at Caron Treatment Centers, Dr. Garbely oversees the following programs and departments: Healthcare Professionals Program, Chronic Pain Program, Neurocognitive Services Department, Psychology, Research, detoxification and, medical management.

During his tenure at Caron, Dr. Garbely spearheaded a high-level initiative to educate and train physicians in addiction medicine through the establishment of the Resident Training Program at Caron Pennsylvania. Dr. Garbely established an Accreditation Council for Graduate Medical Education (ACGME) accredited Addiction Medicine Fellowship Program at Caron Pennsylvania and Reading Hospital. As the Addiction Medicine Fellowship director, Dr. Garbely is a member of the American College of Academic Addiction Medicine. He is also a clinical associate professor at Penn State College of Medicine, an adjunct associate professor at Stony Brook School of Medicine, and a member of the medical staff at Reading Hospital.

Dr. Garbely is the chairman of the Physician in Training Committee of the American Society of Addiction Medicine (ASAM), an ex-officio member of the ASAM Board, and a distinguished Fellow of ASAM. Dr. Garbely received his board certifications through the American Board of Preventative Medicine, Addiction Medicine Subspecialty; the American Board of Internal Medicine; the American Board of Psychiatry and Neurology; and the American Board of Addiction Medicine.

Prior to his current position, Dr. Garbely served as the vice president of medical services and medical director of Caron Pennsylvania. With 20 years of addiction medicine experience, Dr. Garbely has an extensive background in treating substance use disorders, including substance use disorders in healthcare professionals, executives, and pilots. He has worked to develop treatment programs for psychiatric patients involving a 12-Step philosophy. Dr. Garbely has won teaching awards on the local and national level, including the American Psychiatric Association’s Helen Ruske, MD Award for Excellence in Medical Student Teaching.

Dean Drosnes

MD

Dr. Dean Drosnes is the Medical Director of the Pennsylvania campus of Caron Treatment Centers. He holds board certification in Addiction Medicine through the American Board of Preventive Medicine as well as Otolaryngology/Head and Neck Surgery and. He is a Fellow of the American Society of Addiction Medicine and serves on the ASAM Physicians-In-Training Committee. He is a member of the American College of Academic Addiction Medicine, the Pennsylvania Society of Addiction Medicine, and the Alpha Omega Alpha Honor Medical Society. He holds an appointment as Clinical Assistant Professor of Psychiatry, Penn State University College of Medicine.

Dr. Drosnes completed his Fellowship in Addiction Medicine at the University of Maryland. He received his undergraduate degree at the University of Pittsburgh and his medical education from Temple University. He completed his post-graduate training in Otolaryngology/Head and Neck surgery at Thomas Jefferson University.

Dr. Drosnes’ clinical practice focuses on the treatment of co-existing substance use and chronic pain disorders. He emphasizes the integrated use of pain treatment modalities that are compatible with lifelong recovery from addiction.

Olapeju Simoyan

MD, MPH, BDS, FAAFP

Dr. Simoyan is a clinical associate professor in the Department of Psychiatry and Behavioral Health at Penn State College of Medicine and serves as core faculty for the Caron/Reading Hospital addiction medicine fellowship.

Before coming to Caron in February 2020, she was the associate medical director at Geisinger Marworth Treatment Center in Waverly, Pennsylvania, and the program director of Geisinger’s addiction medicine fellowship. She was a member of the founding faculty of the Geisinger Commonwealth School of Medicine (formerly The Commonwealth Medical College) where she held the rank of associate professor of family medicine and epidemiology.

Dr. Simoyan earned her medical degree from Penn State University College of Medicine, after which she completed an internship in psychiatry/family medicine at the University of Pittsburgh Medical Center/Western Psychiatric Institute. She completed her family medicine residency at the Penn State/Good Samaritan Hospital Family and Community Medicine Residency program.

Prior to her medical training, Dr. Simoyan received a dental degree from the University of Ibadan in Nigeria and a Master of Public Health degree from the Johns Hopkins University Bloomberg School of Public Health.

She is board certified in family medicine, addiction medicine, and dental public health and has contributed to international public health education as a Fulbright specialist in Nigeria and an Erasmus Mundus scholar in France and the United Kingdom. She has also volunteered on medical mission projects in Nigeria and Haiti.

Dr. Simoyan is a member of the Addiction Medicine Sub-board of the American Board of Preventive Medicine and serves on the REACH Program Advisory Board, a program that aims to mentor and cultivate culturally responsive fellows and trainees, who are equipped to address healthcare inequities in addiction.

Dr. Simoyan’s scholarships and awards include the Emerging Leader award from the Family Medicine Education Consortium (2010) and the American Association of Medical Colleges’ Herbert Nickens Faculty Fellowship (2012). She was recognized by the Northeastern Pennsylvania Business Journal as one of the “Top 25 Women in Business in 2015,” and she was a second-prize winner in the State Department’s Citizen Diplomacy Challenge in the same year.

ACCME Accredited with Commendation

CME/CE Credits

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this internet-based live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians

This Live activity, The ASAM Fundamentals of Addiction Medicine: A Live Workshop, from 04/02/2020 - 04/02/2021, has been reviewed and is acceptable for up to 8.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Association of Nurse Practitioners
This activity is approved for 8.0 contact hour(s) of continuing education (which includes 2.0 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 20024155. This activity was planned in accordance with AANP Accreditation Standards and Policies.

American Academy of Physician Assistants
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 8.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC)

ABPM Maintenance of Certification (MOC)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

ABA Maintenance of Certification (MOC)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

ABP Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

 ABIM Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABAM Transitional Maintenance of Certification (Tmoc)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ASAM Fundamentals of Addiction Medicine Workshop Planning Committee

Name

Disclosure

Miriam S. Komaromy, MD, FACP, FASAM (Chair)

No Financial Relationships or Conflicts of Interest

Peter L. Selby MBBS, CCFP, FCFP, MHSc, DFASAM, (Immediate Past Chair)

Johnson and johnson: Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support;Pfizer: Consultant/Advisory Board, Other Research Support includes receipt of drugs, supplies, equipment

Zwaantje H. Hamming, FNP-C, CARN-AP

No Financial Relationships or Conflicts of Interest

Marcia Jackson, PhD

No Financial Relationships or Conflicts of Interest

Jill Mattingly, DHSc, MMSc, PA-C

No Financial Relationships or Conflicts of Interest

Lipi Rpy, MD, MPH DABAM

Poynter Institute: Teaching/Training, Honorarium; Florida Hospital: Teaching/Training, Honorarium; Rescue Agency: Consulting, Fee

Kenneth A. Saffier, MD, FASAM

No Financial Relationships or Conflicts of Interest

Mario F. San Bartolomé, MD, MBA, MRO, QME, FASAM

No Financial Relationships or Conflicts of Interest

J. Paul Seale, MD, FASAM

No Financial Relationships or Conflicts of Interest

Alexander Walley, MD, MSc, FASAM

No Financial Relationships or Conflicts of Interest

 

ASAM CME Committee

NameNature of Relevant Financial Relationship
Cara Poland, MD, MEd, FACP, DFASAM, ChairNone
Catharina Armstrong, MD, MPHNone
Subhadeep Barman, MD, FASAM, FAPANone
Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
What was received: Common stock
Role: None
Commercial Interest: Baxter International
What was received: Common stock
Role: None
Commercial Interest: Takeda Pharmaceuticals
What was received: Common stock
Role: none
R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
What was received: Travel expenses
Role: Speaker
Zwaantje H. Hamming, FNP-C, CARN-APNone
Herbert L. Malinoff, MD, FACP, DFASAM None
Noel Ilogu, MD, MRCP, DFASAMNone
Edwin A. Salsitz, MD, DFASAMNone
 ASAM Staff and Consultants
Arlene C. Deverman, MA, CAE, CFRENone
Sandy MetcalfeNone
Kate M. BrundageNone

Caron Treatment Centers

With 60 years in the field, Caron Treatment Centers operates lifesaving addiction and behavioral healthcare treatment. Caron is headquartered in Wernersville, Pennsylvania, with Ocean Drive and Caron Renaissance located in Palm Beach County, Florida. Caron has recovery centers in New England, Philadelphia and Washington, D.C., which offer community and recovery support. Caron’s Recovery Centers in Atlanta and New York City also offer pre- and post-treatment services. 

Caron has the most extensive continuum of care including teens, young adults, mid-life adults, older adults, chronic pain, executives, healthcare and legal professionals and families. Caron’s treatment is customized to meet the needs of individuals and families – with highly trained teams prepared to address co-occurring disorders. Caron offers an innovative approach to ongoing recovery care support for its patients and their families with online peer groups and other resources during the first year of transition following discharge.